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Available online 8 June 2014Abstract Optimization of pluripotent stem cell expansion and differentiation is facilitated by biological tools that permit
non-invasive and dynamic monitoring of pluripotency, and the ability to select for an undifferentiated input cell population.
Here we report on the generation and characterisation of clonal human embryonic stem (HES3, H9) and human induced
pluripotent stem cell lines (UQEW01i-epifibC11) that have been stably modified with an artificial EOS(C3+) promoter driving
expression of EGFP and puromycin resistance-conferring proteins. We show that EGFP expression faithfully reports on the
pluripotency status of the cells in these lines and that antibiotic selection allows for an efficient elimination of differentiated
cells from the cultures. We demonstrate that the extinction of the expression of the pluripotency reporter during
differentiation closely correlates with the decrease in expression of conventional pluripotency markers, such as OCT4
(POU5F1), TRA-1-60 and SSEA4 when screening across conditions with various levels of pluripotency-maintaining or
differentiation-inducing signals. We further illustrate the utility of these lines for real-time monitoring of pluripotency in
embryoid bodies and microfluidic bioreactors.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
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(http://creativecommons.org/licenses/by-nc-nd/3.0/).medicine and are potentially powerful tools for therapeutic
drug screening (Inoue and Yamanaka, 2011; Rowntree and
McNeish, 2010). Despite recent rapid advances in our ability
to expand these cells as pluripotent cells (Ungrin et al.,
2008) and direct their differentiation into a range of desired
cell lineages (Keller, 2005), much is to be learned about the
extrinsic and endogenous factors produced that control
these processes, and how these are modulated by cell–cell
contact signalling and other features of the microenviron-
ment. The ability to genetically manipulate mouse ES cellsis an open access article under the CC BY-NC-ND license
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inducible tissue-specific, cell-specific or gene-specific fluo-
rescent reporters has greatly accelerated our understanding
of pluripotent stem cell biology. However, in the case of
human pluripotent cells the development of such tools has
been much slower, mainly because of the inefficient nature
of homologous recombination in human pluripotent cells,
the difficulty in obtaining clonal populations of cells,
and their inherent genetic and epigenetic instability in
culture. The derivation of transgenic, clonal, and karyo-
typically normal human pluripotent stem cell lines is
therefore a non-trivial endeavour. Furthermore, there is
the obvious inability to perform human blastocyst injection
of geneticallytagged ES cells, an assay that is widely used in
mice to exemplify the efficacy of ES and iPS cell reporters.
Given the intrinsic differences between mouse and human
ES cells in terms of molecular pathways maintaining
pluripotency and inducing lineage-specific differentiation,
and the need to isolate pure populations of lineage-specific
progenitors (or the identification of specific cell surface
markers thereof), a number of laboratories have undertaken
the arduous task of genetically tagging promoters and genes
of interest using either classical homologous recombination
or zinc finger/TALEN-based genome editing techniques (Liu
et al., 2011; Zou et al., 2009; Zwaka and Thomson, 2003). It
is, however, becoming increasingly clear that human embry-
onic stem cell lines differ intrinsically in their ability to grow
and respond to pluripotent cell culture conditions and also
possess different biases in their propensity to undergo
differentiation into specific cell types (Lepski, 2012). This is
most evident when comparing human iPS cell lines derived
from different cell types or generated through different
methods (Alvarez et al., 2012). Understanding and harnessing
these different propensities of human pluripotent cell lines,
properties most likely influenced by both genetic background
and epigenetic parameters, is one of the major current
challenges in the stem cell field (Tobin and Kim, 2012).
With the recent advent of iPS cells and their wide potential
in the field of regenerative medicine, the propensity of
differentiated, iPS-derived cells to revert back to a pluripotent
phenotype is particularly topical (Pera, 2011). Hence, the
ability to identify, and ultimately eliminate, the cells that
retain these undesired pluripotent properties after directed
differentiationwill be essential for regenerativemedicine. One
of the most viable and attractive approaches to this end is the
genetic tagging of cells which, in turn, requires the identifica-
tion of the best promoters capable of reporting on such cells.
There is thus a clear need for tools that allow for the
rapid and facile delivery of gene reporters to human
pluripotent stem cells that faithfully report on pluripotency
and differentiation. Lentiviral delivery of fluorescent pro-
moter reporters is clearly an attractive solution, and a
family of selectable fluorescent reporter lentiviruses has
been described by Hotta et al. (Hotta et al., 2009a,b).
Various promoters have been trialled for their ability to
drive expression specifically in pluripotent cells, and the
artificial OCT4/POU5F1 promoter sequences-based promot-
er driving expression of both EGFP and puromycin N-acetyl-
transferase (conferring puromycin resistance), used in this
study, appears to provide the highest efficiency and
specificity in human pluripotent ES (hES and iPS) cells
(Hotta et al., 2009a). Here we report on the generationand verification of the pluripotent stem cell lines with the
lentivirallydelivered EOS(C3+)-EGFP-IRES-PURO transgene
that both reports on pluripotency and, of key importance,
allows for the selection of pluripotent stem cells.
Materials and methods
Pluripotent and differentiated cell culture
conditions and cell lines
hES and iPS cells were cultured in feeder-free conditions in
xeno-free definedmedium,mTeSRTM1 (StemCell Technologies,
Vancouver, BC) or NutriStem (Stemgent) on Matrigel™ (BD
Biosciences at 1/100 dilution) coated tissue culture plastic
surfaces. NutriStemmediumwas supplemented with 10 ng/mL
FGF2 (Invitrogen/Life Technologies) for hES and 50 ng/mL for
iPS cell line propagation. Cells were passaged as clumps using
dispase (Gibco/Life Technologies) digestion at 1.5 mg/mL. For
a typical 2D differentiation protocol, cells were grown in a
6-well plate to ~50% confluence in the presence of 2 μg/mL of
puromycin, and the medium changed to selection-freeKSR
medium (Chung et al., 2010), with or without inducers of
differentiation, either 10% FCS or 5 μM retinoic acid (RA). Cells
were harvested at 2–6 days after induction of differentiation.
HES3 and H9 hES cell lines were provided by the UQ AIBN
StemCore (www.stemcore.com.au). The UQEW01i-epifibC11
iPS episomally derived cell line (referred to as WT11TF for
brevity from now on) was described previously (Briggs et al.,
2012; Nayler et al., 2012). At least three independent clones
from hES and iPS parental cell lines with representative
characteristics (levels of reporter expression in pluripotent
state, reporter inactivation dynamics) were used for analysis.
Lentiviral transduction of the pluripotent stem cells
Lentiviral and packaging vectors, pCMVΔR8.2 and pVSV-G,
were co-transfected into the 293FT cell line (Invitrogen) for
viral particle production as described in Whitworth et
al.(2012). HES3 and H9 hES cells adapted to passaging as a
single-cell suspension, as described previously (Hudson et
al., 2012), as well as the hESC and UQEW01i-epifibC11
lines maintained as bulk cultures on Matrigel™ substrate(BD
Biosciences), were transduced with lentiviral particles and
maintained in mTeSRTM1/Matrigel cultures under selection
in the presence of 2.5 μg/mL of puromycin. Putative single
cell-derived colonies homogeneous for moderate to high
EGFP expression were generated from HES3 and H9 cell lines
and transgene-free iPS clone WT11TF (UQEW01i-epifibC11).
The following plasmids were obtained from Addgene (MA,
USA) and used for lentivirus production: Addgene plasmid
21312 PL-SIN-PGK-EiP, 21313 PL-SIN-EOS-C(3+)-EiP (used to
produce the described EOS(C3+)-EiP reporter lines), 21314
PL-SIN-EOS-S(4+)-EiP.
Analysis of the reporter and pluripotency marker
expression
Flow cytometry
Analysis of cell surface markers was carried out essentially
as described in Ovchinnikov et al.(2012) and Whitworth
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suspension using TrypLE or Cell Dissociation Buffer (Invitrogen)
and stained live with anti-TRA-1-60 1/300 (MAB4360, Millipore),
anti-SSEA4 1/400 (MAB4304, Millipore), anti-TG30 1/400
(MAB4427, Millipore), or with anti-OCT4 (MAB4419, Millipore)
after 10 min fixation in 2% neutralised PFA and perme-
abilization with TritonX-100. For blocking, antibody incuba-
tion and permeabilization (when applicable) steps, PBS
containing 10% heat-inactivated goat serum (Hyclone) and
0.1% TritonX-100 (0.4% for permeabilization) was used. For
flow cytometry secondary antibodies anti-mouse IgG (H + L)
AlexaFluor488 or anti-mouse IgM AlexaFluor488 (Molecular
Probes/Invitrogen, Carlsbad, USA) were used at a 1/1000
dilution. Isotype control antibodies at identical concentra-
tions as the primary antibodies were used to set the gates.
Flow cytometry data were collected using BD LSRII or
AccuriCFlow C6 cytometers, and analysed using AccuriCFlow.
Immunofluorescence
The primary antibodies used for immunofluorescence
were: anti-Oct3/4 (C10, sc5279 SantaCruz) at 1/75, anti-
Sox2 (AB5603, Millipore) at 1/100, anti-NANOG (9220
Millipore) at 1/150. Secondary antibody: anti-mouse IgG
(H + L) AlexaFluor488 (Molecular Probes/Invitrogen) was
used at a 1/1000 dilution. Isotype controls at similar
dilutions to the primary antibodies were used to assess
non-specific binding. No significant labelling was detected
in isotype control-incubated samples (data not shown).
Counter-staining of the nuclei was performed using Hoechst
33342 nuclear dye (Invitrogen/Life Technologies) at 0.1 μg/mL
in PBS.
Statistical analysis of the reporter and surface
marker correlation
To correlate the extinction of pluripotency reporter-
drivenEGFP fluorescence with the surface pluripotency
markers, flow-cytometric analysis was performed on cells
from 2D differentiation cultures at their intermediate stages:
i.e. when the majority of the cells possessed an intermediate
level of surface marker expression and differentiation pheno-
type. Fluorescence readings corresponding to single-cell
events (gated on forward and side scatter plots and peak
width) were exported in text (*.csv) format using Weasel v2.7
software (WEHI, Melbourne, Australia). Spearman’s rank test
analysis was performed as described in McDonald(2009). For
calculations n N 1000 was used, thus providing high confi-
dence in the significance of the correlation (p b 0.01).
Reporter cell line evaluation in multifactorial
microbioreactor array-based assays
Data from full-factorial microbioreactor array screening exper-
iments using a previously described system (Hudson et al., 2012)
were used to compare EOS-GFP expression with TG30 and
TRA-1-60 expression levels. Briefly, microbioreactors were
fabricated and sterilised, surface-coated with 400 μg/mL
purified human fibronectin (BD Biosciences), and seeded with
HES3::EOS(C3+)-EiP hESCs at ~4 × 104 cells/cm2 in mTeSRTM1
without FGF2 and TGFβ1 (StemCell Technologies) with
inclusion of 10 μM ROCK inhibitor (Sigma-Aldrich). Cells wereallowed to attach for 8–10 h then cultured for 6.5 days under
60 μL/h continuous fluid flow, under the panel of conditions
shown in Fig. 3E. At the endpoint, arrays were stained for
TRA-1-60 and with Hoechst33342, and then imaged with a Zeiss
LSM 710 laser scanning confocal microscope, with optical
sections processed into a maximum intensity projection
for image analysis. Total fluorescence intensities (TEOS-GFP,
for example) were extracted from array images with AGScan
(https://mulcyber.toulouse.inra.fr/projects/agscan), and in-
dividual spot intensities in each channel were linearly
transformed about the mean and standard deviation for
all spots in that channel in an individual array, by IEOS-GFP =
(TEOS-GFP− μEOS-GFP)/σEOS-GFP, where IEOS-GFP is termed the
expression index of EOS-GFP, and μEOS-GFP is the mean and
σEOS-GFP the standard deviation of all spot intensities (TEOS-GFP)
for a particular array.Assessment of the differentiation potential of the
pluripotency reporter cell lines
The differentiation potential of EOS(C3+)-EiP cell lines was
assessed using both in vitro embryoid body formation and in
vivo teratoma formation assays. For embryoid body
formation, cells were digested using dispase with subse-
quent resuspension in KSR medium (20% KnockOutTM
Serum Replacement in DMEM/F12 medium (both from
LifeTechnologies), full description in Chung et al.(2010), in
a well of a 6-wellultra-low attachment polystyrene plate
(Falcon)). For the teratoma formation assay, a pellet of
5 × 105 cells was formed in the presence of Matrigel matrix
at 1:50 dilution, and injected intramuscularly into the thigh
muscle of a NOD/SCID mouse. Teratomas were harvested
within 4–8 weeks, fixed and processed for paraffin embed-
ding and histological analysis. Haematoxylin/eosin-stained
5 μm sections were permanently mounted, microscopically
analysed and imaged on an Olympus IX51 inverted microscope
equipped with MicroPublisher 3.3 RTV CCD camera (QImaging).
For directed differentiation, we utilised previously described
protocols for neuronal (Briggs et al., 2012) differentiation from
the hPSCs.Analysis of the pluripotency and lineage-specific
marker expression in embryoid bodies derived from
EOS(C3+)-EiP human pluripotent cell lines
Downregulation of the expression of the conventional
markers of pluripotency (POU5F1 and SOX2) and selected
markers of differentiation into the three major germ layers
and their derivatives (PAX6, EOMESODERMIN and CDX2) were
assayed using a qPCR-based approach. Briefly, total RNA was
isolated using the Nucleospin RNA II kit (Macherey-Nagel)
according to the manufacturer’s protocol. 1 μg of isolated
total RNA was utilised to synthesise cDNA using the iScript
cDNA synthesis kit (Bio-Rad) according to the manufacturer’s
protocol. qPCR reactions comprised of Ssofast Evagreen
(Bio-Rad) reaction mix and cDNA template were performed
using the C1000 Thermal Cycler (Bio-Rad). All measured
genes had their corresponding quantitative levels normal-
ised to endogenous GAPDH. Primer sequences can be found
in Table 1.
Table 1 Gene targets and their corresponding primer sequences utilised for qPCR analysis.
Gene target Forward primer Reverse primer
POU5F1 TGAAGCTGGAGAAGGAGAAG ATCGGCCTGTGTATATCCC
SOX2 CCACCTACAGCATGTCCTACTCG GGGAGGAAGAGGTAACCACAGG
CDX2 GGAGCTGGAGAAGGAGTTT TGATTTTCCTCTCCTTTGCTC
PAX6 CAGCACCAGTGTCTACCAACCA CAGATGTGAAGGAGGAAACCG
EOMES CAAATTCCACCGCCACCAAACTGA TTGTAGTGGGCAGTGGGATTGAGT
GAPDH ATGGGGAAGGTGAAGGTCG TAAAAGCAGCCCTGGTGACC
SOX17 GGCGCAGCAGAATCCAGA CCACGACTTGCCCAGCAT
SOX2-2 GCTACAGCATGATGCAGGACCA TCTGCGAGCTGGTCATGGAGTT
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Generation and characterisation of EOS reporter lines
Human embryonic stem cell lines HES3 and H9 and
the non-viral, integration-free human iPS cell line WT11TF
(UQEW01i-epifibC11 (Briggs et al., 2012)) were cultured
under feeder-free conditions in mTeSRTM1 or MEF-
conditionedmedium, and transduced with high titre
lentiviral preparations produced using the EOS(C3+)-
EGFP-IRES-PURO (from this time referred to as EOS(C3+)-
EiP) constructs (Hotta et al., 2009a). By day 5, up to 5% of
hES/iPS cells were found to express GFP. Such cultures were
next allowed to expand for 3 more days before selection for
stable integration of the transgene through the addition of
initially 2 μg/mL puromycin, with a further increase to
2.5 μg/mL puromycin after day 6. After 12–16 days, we
observed an almost homogeneous expression of EGFP in
some colonies of surviving hESC and iPSC (Supplementary
Fig. 1F). These colonies were next harvested, expanded and
cryopreserved. During continued passaging of EOS(C3+)-EIP
hES and iPS cells we observed the well-known sporadic
inactivation of lentiviral transgenes previously observed in
hPSCs (Liew et al., 2007; Xia et al., 2007), as indicated by
the “salt-and-pepper” pattern of EGFP-expressing cells
interspersed with those that have lost the expression
(best illustrated in Supplementary Fig. 1C), most likely due
to epigeneticallydriven lentiviral transgene inactivation.
However, the addition of puromycin to such cultures allowed
facile deletion of the vast majority of such cells (Supple-
mentary Fig. 1C, L, also discussed further in Section 3.3).
Clones displaying highlyhomogeneous and penetrant expres-
sion of the reporter transgene were picked for further
characterisation (Fig. 1B, F,H and Supplementary Fig. 1G-I).
EOS(C3+)-EIP lentivirallytransduced hESC and iPSC were
expanded for more than 20 weekly passages and exhibited
normal karyotypes (Supplementary Fig. 1) and expressed
high levels of the pluripotency-controlling transcription
factors POU5F1/OCT4, SOX2 and NANOG (Fig. 2A) by
immunofluorescence and Oct4 and SOX2 by FACS (Table 2).
When under constant selection, the fraction of EGFP-
expressing resistant cells in single cell-derived clones was
found to be consistently high in all hPSCs, specifically
90.14 ± 3.2% (5 clones) for HES3 hESC and 93.5 ± 2.7% (5
clones) for WT11TF iPSC (also see Table 1). The pluripotency
of stable EOS lines was confirmed by RT-PCR analysis of
embryoid bodies (EBs), which demonstrated expression ofmarkers of all three germ layers and their derivatives
(Supplementary Fig. 2). Furthermore, both hESC and iPSC
EOS lines formed teratomas in NOD-SCID mice that
exhibited cell types representative of the three germ
layers (Fig. 2E-G for hESC-derived EOS clones and Supple-
mentary Fig. 2 for iPSC-derivedEOS clones). In situ analysis
of GFP expression in cultured hESC and iPSC lines indicated
an excellent correlation between the loss of EGFP fluores-
cence and morphological signs of differentiation (Fig. 1I-J),
such as those typically occurring at the centres of hES and
iPS colonies.Enrichment for pluripotent cells improves directed
differentiation protocols
Because differentiated cells excrete paracrine factors
and impose confounding cell–cell interactions on human
pluripotent stem cells, homogeneous and efficient differ-
entiation protocols generally require (or at least greatly
benefit from) a pure pluripotent starting population,
e.g. Hudson et al.(2012). The presence of the EOSpromoter-
driven puromycin antibiotic selection marker allows for a
rapid deletion of any differentiated cells from such cultures
(e.g. Fig. 1K where the EGFP-IRES-puro cassette is driven by a
ubiquitous PGK promoter compared to a colony in Fig. 1L
utilising the EOS(C3+) promoter). Nearlycomplete ablation
could be achieved in as little as 2–3 days due to the potent
nature of the puromycin selection, causing rapid death and
detachment of non-resistant cells (Supplementary Fig. 1L and
data not shown).
To exemplify the benefits of this selection, we cultured
three WT11TF::EOS(C3+)-EiP clones for 3 weeks in parallel
in conditioned medium containing 50 ng/mL bFGF with and
without puromycin selection. Subsequent flow-cytometric
analysis showed that the antibiotic-selected population
contained 1.7 ± 0.5% of POU5F1/OCT4− cells (N = 3) whilst
the similarly cultured non-selected populations contained
9.3 ± 2.3% (N = 3) POU5F1/OCT4− cells (Fig. 2H). We next
assessed whether this difference in starting population
affects the efficiency of neuronal differentiation (see Methods
section). Indeed, after 6 days of directed neuronal differenti-
ation, puromycin-selected cultures displayed 31 ± 4.2% PAX6+
neuroepithelial progenitors, as measured by flow cytometry
with anti-PAX6 antibody, whereas unselected cultures show
20 ± 5.1% PAX6+ cells (N = 3, Fig. 2H and Supplementary
Fig. 2D).
Figure 1 Cellular distribution of reporter fluorescence in the EOSpromoter-based reporter lines grown in feeder-free
conditions. A,B.Corresponding phase-contrast and EGFP epifluorescence images of a HES3 hES cell line-based EOS(C3+)-EiP colony
grown under puromycin selection. C,D.Flow cytometry histograms illustrating consistently high levels of EOS(C3+)-EiP expression in 3
puromycin-selected HES3 EOS(C3+) clones. Parental cell line HES3 (orig) was used as a control. E,F. Phase contrast and epifluorescence
images of a typical H9 hES EOS(C3)-EiP colony.G,H.Images of the transgene-free iPS line UQEW01i-epifibC11-based EOS(C3+)-EiP cell line
colony. (A,B and E-H are all passage 2 after transduction and continuous puromycin selection).I,J.Phase-contrast and epifluorescence
images of the iPS (UQEW01i-epifibC11) EOS(C3+)-EiP cell lines’ colonies following partial spontaneous differentiation in their central
portions. Prominent drop in the reporter fluorescence correlates with morphological signs of differentiation. K,L.Phase-contrast images
of the edges of HES3::PGK-EiP (K) and HES3::EOS(C3+)-EiP (L) colonies, respectively, grown in presence of 2 μg/mL of puromycin,
illustrating efficient elimination of fibroblast-like differentiated cells from the colony’s edges in EOS(C3+)− but not in the ubiquitous
PGKpromoter-drivenEGFP and puromycin HES3 line. Scale bars = 20 μm.
255Selectable stable pluripotency reporter hPSC lines in pluripotency and differentiationValidation of the functionality of the pluripotency
reporter lines
In time-lapse videos of differentiating colonies of the
reporter clones a very good concordance between the EGFP
extinction and morphological changes associated with
differentiation is apparent (Supplementary Videos 1–3),
with central areas of colonies inactivating the reporter
and acquiring a differentiated morphology first. Complete
extinction of reporter fluorescence was observed after
6 days of withdrawal of the pluripotency-maintaining fac-
tors, addition of foetal calf serum (FCS) or supplementation
with retinoic acid at 5 μM (Fig. 3A).
Since the conventional variant of the EGFP protein
was used in the construction of the transgene it was
important to verify the dynamic response range and kinetics
of EGFP downregulation during differentiation of the
reporter lines in comparison with the expression of other
widelyused pluripotency markers. To this end we allowed
reporter-containing hESC and iPSC to undergo spontaneous
differentiation, through the withdrawal of FGF and
TGFβ from the culture medium, or induced differentiationthrough addition of retinoic acid to the medium, and
assessed EGFP and pluripotency marker expression at days
0, 2, 4 and 6. Downregulation of EGFP occurred more rapidly
and more completely than downregulation of the widelyused
pluripotency markers TRA-1-60, TG30 and SSEA4 (Fig. 3C, D,
Supplementary Fig. 3B, C), and correlated very closely
with the downregulation of OCT4 expression (Fig. 3C,
Supplementary Fig. 3C) for both hESC-derived (Fig. 3) and
iPS-derived (Supplementary Fig. 3) reporter clones. Down-
regulation of the reporter followed the decrease in levels
of OCT4 protein with a ~24 h lag period resulting in a
population of cells with reduced OCT4 expression but
still retaining detectable levels of EGFP reporter protein
expression (Fig. 3C). This observation is consistent with the
stability of the EGFP mRNA (Cubitt et al., 1995), the half-life
of EGFP protein of around 26 h in mammalian cells (Corish
and Tyler-Smith, 1999) and the fact that OCT4 is itself is a
direct regulator of the reporter promoter.
Flow-cytometric analysis revealed a high concordance
between EGFP expression and expression of pluripotency
cell surface markers such as TRA-1-60 and SSEA4 (represen-
tative raw data plots shown for TRA-1-60 in Fig. 3B, and for
Figure 2 Validating pluripotency and differentiation potential of the EOS(C3+)-EIP pluripotency reporter in hESC and iPSC
lines, and their utility in improving directed differentiation. A. An immunofluorescent staining for OCT4/POU5F1 and SOX2 in
representative HES3::EOS(C3+)-EiP colonies grown under puromycin selection. Scale bar = 20 μm. B-D. Flow-cytometric analysis of
EGFP reporter and surface marker expression (SSEA4 and TRA-1-60) in a HES3 EOS(C3+)-EiP hES cell line grown for 1 day without
selection. E-G. Histological teratoma sections derived from HES3::EOS(C3+)-EiP cell line, demonstrating fullydifferentiated tissues
derived from the three germ layers: mesoderm (E, cartilage), ectoderm (F, retinal pigmented neuroepithelium-like) and endoderm
(G, secretory epithelium and goblet-like cells lining a mucus-filled cavity, *). Haematoxylin/eosin staining on 5 μm-thick paraffin
sections, scale bar = 100 μm. H.Flow-cytometric analysis of the difference in loss of pluripotency marker POU5F1/OCT4, and
subsequent acquisition of expression of the neuroepithelial marker PAX6 in iPS-derived reporter clone grown with (green) and without
(blue) selection.
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basedtest is most suitable for assessment of general trends
of this type, as it is not based on any assumption of the
nature of the sample’s distribution. The correlation
appeared to be very good with Spearman’s rho values ≥0.7
for EGFP and surface markers, N0.8 for TRA-1-60(rs = 0.81 ±
0.9%, n = 3) and rs N0.7 for SSEA4 (Supplementary Fig. 3A and
data not shown).
Collectively these data demonstrate that EGFP expres-
sion in lentivirallygenerated hESC and hiPSC EOS(C3+)-EiP
pluripotency reporter lines faithfully and dynamically re-
ports on pluripotency and that such lines behave as normal
human pluripotent cell lines.Pluripotency screening in a multifactorial
microbioreactor array
The pluripotency reporter cell line HES3:EOS-C(3+)-EiP was
seeded into the microbioreactor array (Titmarsh et al.,
2012, 2013) and subjected to factorial combinations of the
pluripotency maintenance factors FGF2 and TGFβ1 and
the differentiation-inducing factor retinoic acid (RA) using
the concentrations listed in the panel in Fig. 3E. After
continuous slow perfusion culture for 6.5 days under these
conditions, cells had proliferated and showed morphological
differences between various treatments, and expressed GFP
under the control of the EOS(C3+)-EIP promoter construct.
Table 2 Characterisation of stable EOS(C3+)-EiP hPSC clones used in this study.
Cell type Cell line Clone Karyotype % EGFP+ ⁎ % OCT4+ ⁎ % TRA-1-60 ⁎ NANOG+ (IF ¥)
hES HES3 3.1 Normal ♀ 91.2 97.1 97.9 Yes
3.2 Normal ♀ 89.7 96.9 98.2 Yes
3.3 N/A 86.8 96.2 98.0 Yes
H9 #1 Normal ♀ 91.7 96.7 97.1 Yes
#2 Normal ♀ 94.2 98.6 99.3 Yes
#3 Normal ♀ 92.3 99.3 98.4 Yes
iPS WT11TF #1 Normal ♂ 93.8 98.1 98.9 Yes
#2 Normal ♂ 94.1 98.3 97.9 Yes
#3 Normal ♂ 92.3 97.8 98.4 Yes
N/A, not available.
⁎ In cultures kept under continuous selection with 2 μg/mL puromycin for 2 weeks.
¥ N95% positive by immunofluorescent staining for nuclear NANOG protein.
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exhibited a high dynamic range (bright expression and
efficient extinction) and sensitive response. The presence
of 5 or 10 μM RA reduced EOS(C3+)-EIP expression to a
baseline level regardless of FGF2 or TGFβ1 treatment. Also,
treatments lacking maintenance factors (FGF2 and TGFβ1,
Column 1) or with insufficient factors (0.25 ng/mL TGFβ1,
Column 4) had similar EOS(C3+)-EIP expression to RA-treated
conditions, showing sensitivity to absent or insufficient
pro-maintenance signals. Supply of sufficient maintenance
factors (Column 25, for example) maintained high-level
expression. The highest response for all 3 pluripotency
markers occurred at Column 25 (100 ng/mL FGF2, 0.5 ng/mL
TGFβ1), which corresponds to reconstituted composition of
original mTeSRTM1 maintenance medium.
TRA-1-60 exhibited a lower dynamic range than
EOS(C3+)-EIP, and had higher residual expression, resulting
in “false-positive” readouts in pluripotency non-maintaining
environments in some differentiating conditions in the array
(Fig. 3D and figure legend, and Fig. 3C and Supplementary
Fig. 2). As a result of this, levels of TRA-1-60 expression,
both when normalised across the microbioreactor (Fig. 3E)
or against the chamber’s DNA contents (data not shown),
varied more widely than EOS(C3+)-EIP and thus were
less sensitive as an indicator of differentiation, whilst
the reporter expression appeared to correlate well with
the conditions favouring maintenance of pluripotency, and
showed robust downregulation in all RA-containing environ-
ments (Fig. 3E).Persistence of the EOS(C3+)-EIP reporter uncovers
heterogeneity amongst embryoid bodies in
differentiation assays
To investigate extinction dynamics of the pluripotency
reporter in a 3D setting, we next subjected hESC and
iPSC reporter lines to embryoid body (EB) differentiation
protocols. Conventional analysis of lineage-specific marker
expression on pooled EBs after 8 weeks shows the expected
overall decrease in expression of both OCT4/POU5F1 and
SOX2, and upregulation of the neuronal (PAX6, TUBB3),
posterior endoderm (CDX2) and mesoderm (EOMESODERMIN)
lineage markers that is routinely reported in the literature(Supplementary Fig. 2). However, in situ examination of
EGFP expression in EOS(C3+)-hESC and iPSC reporter clone
derived suspension EBs revealed an unexpected persistence
and remarkable inter-EB diversity (Fig. 4A-F). Whilst
there was a marked and expected overall downregulation
of reporter expression after 2 weeks in culture when
compared to freshly generated EBs (Fig. 4C), a large
proportion of the EBs retained low levels of EGFP expression
(Fig. 4C,C′). After 6 weeks of suspension culture in KSR
medium without pluripotency-maintaining factors a number
of EBs (~70%, increasing with time in culture) lost all, or
most, of the EOS(C3+)-EIP reporter-drivenEGFP fluorescence
(Fig. 4F). These EBs were typically smaller, and started to
form cavities or cyst-like structures (Supplementary Fig. 4B,
C). Pooling of the 6 week-oldEGFP-low and EGFP-negative
EBs followed by a qPCR analysis revealed that EBs retaining
reporter fluorescence maintained higher levels of residual
OCT4/POU5F1 (tested using 2 distinct qPCR primer sets),
its downstream target LEFTYA, and higher levels of the
mesodermal marker EOMESODERMIN (Supplementary
Fig. 4A). On the other hand, low EGFP-expressing EBs
showed similar expression levels of SOX2 (a direct regulator
of the EOS promoter, also tested using 2 distinct qPCR assays,
one of which is shown in Supplementary Fig. 4A), DNMT3A
(a pluripotency-associated DNAmethyl-transferase), PAX6
(a neuroectodermal marker) and TUBB3 (a neuronal marker)
(Supplementary Fig. 4A). By week 12 virtually no EGFP
expression was detected in any of the EBs (Fig. 4F, Supple-
mentary Fig. 4C,D), indicating that this persistence of EGFP
expression in a subset of 6 week-old EBs that appears to
undergo mesodermal differentiation is not due to an intrinsic
inability to downregulate the reporter. Identification of this
unexpected heterogeneity within EB pools would not have
been possible without the use of the pluripotency reporter and
is one example of its utility.Discussion
The ability for live monitoring of the pluripotency status
of stem cells is important for both optimisation of growth
and differentiation conditions, and assessment of the
retention and extinction of pluripotency by stem cell lines,
in particular iPSCs, during differentiation. The EOS promoter
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Figure 4 Use of the EOS reporter reveals heterogeneity within pools of spontaneouslydifferentiating embryoid bodies (EBs).
A. Fluorescent image of representative EBs 2 days after formation. B. EBs 1 weeks after formation retain high levels of EOS(C3+)-EiP
reporter fluorescence. C, C′. Fluorescent and bright-field images of EBs 2 weeks into differentiation, when a number of EBs (b10%)
fully inactivate the reporter. D, D′. Representative images of both types of EBs at 6 weeks of differentiation that clearly retain
(EGFP+) or extinguish (EGFP−) the reporter expression in majority of their cells, and were used for the differential expression
analysis. E, E′. By 8 weeks, only low level of EGFP expression persists in some of the EBs, and virtually all expression is lost by week 12
(see Supplementary Fig. 4). F. Representation of the quantification of EGFP + and EGFP− fractions in iPSC-reporter derived EBs.
Scored EB number N N 40 for each time point. G. qPCR analysis of the expression of pluripotency marker POU5F1/OCT4, and
mesodermal (EOMESODERMIN) and neuroepithelial (PAX6) markers in EGFP+ and EGFP− EBs at 6 weeks. Persistence of EGFP correlates
with high levels of residual POU5F1/OCT4 expression. See Discussion for more detail. Data for all genes is normalised against the
internal GAPDH control, error bars–SEM values (N = 3). Scale bar = 500 μm.
259Selectable stable pluripotency reporter hPSC lines in pluripotency and differentiationtested is available in 2 variants, with tandemly concatenated
OCT4/SOX2 binding sites derived from either the OCT4/POU5F1
promoter (C3, 3 copies) or SOX2 promoter (S4 variant, 4 copies)
(Hotta et al., 2009a,b). Clonally derived hES lines were
originally generated using both variants, but preliminary
analysis showed that the former (C3+) variant tended toFigure 3 Utility of the EOS(C3+)-EiP reporter lines for assessmen
reporter fluorescence levels illustrating effects of various different
HES3::EOS(C3+). B. Plot illustrating the correlation between EGFP
after 3 days of FCS-induced differentiation as measured by flow cy
double decimal logarithm scale plot. Spearman’s rho coefficient
measurements illustrating kinetics of the decrease in OCT4 and EGFP
illustrating dynamics of OCT4, EGFP, TRA-1-60 and TG30 extinct
differentiation in the KSR medium E. Expression indices (see Meth
reporter and TRA-1-60 in microbioreactor during factorial analy
maintenance of pluripotency in a HES3 reporter cell line. Reporter an
normalised against DNA content. Fluorescence indices are plotted aproduce lines with more consistent reporter expression and
responsiveness across a wider range of basal fluorescence
levels, and produced a larger fraction of puromycin-resistant
clones that were EGFP+ (78% vs. 62%, n = 50 for HES3).
It is likely that a pluripotency reporter construct could be
a useful tool to drive “suicide gene”-based cassettes andt of the pluripotency status. A. Histogram of the distribution of
iation-inducing conditions on the expression of the reporter in
fluorescence and TRA-1-60 expression in HES3::EOS(C3+)-EiP
tometry. Only 300 events (for visual clarity) were plotted on a
for this plot rs = 0.82. C.Contour-plots of the flow-cytometric
expression in differentiating HES3::EOS(C3+)-EiP. D. Histograms
ion in a HES3::EOS(C3+)-EiP clone during the time course of
ods and Titmarsh et al.(2013) for definition) of EOS(C3+)-EIP
sis of the effects of FGF2, TGFβ1 and RA concentration on
d surface marker fluorescence reading for each of the wells was
s mean ± SD.
260 D.A. Ovchinnikov et al.delete unwanted stem cells that either retain or re-acquire
pluripotency in iPSC-derived grafts. In this study we show
that the reporter is rapidly extinguished during various
directed and spontaneous differentiation protocols, with
more efficient extinction in neurally biased embryoid body
differentiation, but can maintain residual expression for
extended periods in cells that differentiate into embryoid
bodies biased towards the mesodermal lineage. Reporter
expression is eventually lost in the majority of cellular
aggregates (EBs) after 6 weeks and from all cells after
12 weeks of EB-based differentiation, identifying the time
window when such deletion strategies should commence in
vivo. One could further envisage that the lentiviral delivery
of the reporter to newly generated iPS cell lines could be
used as a tool to screen such lines for their propensity to
re-acquire pluripotency following differentiation, e.g. as
EBs, and study the molecular basis of this unwanted
property.
In the shorter term the greatest utility of these lines lies
in their ability to report on pluripotency in real time. We
exemplify that human pluripotent stem cell lines that stably
express the reporter allow monitoring of the pluripotency
states of individual cells in a wide spectrum of experimen-
tal settings (e.g. Titmarsh et al., 2013). These lines are
particularly valuable for microbioreactor arrays, bioengineer-
ing applications, and other applications requiring non-intrusive
and continuous monitoring regimes such as screening of culture
surfaces.
The reporter lines allowed us to observe in real time that
colonies with greater than 300 cells displayed slightly higher
expression levels of the reporter at the colonies’ outermost few
cell layers (Fig. 1A, F, fluorescence profiles across colonies
shown in Supplementary Fig. 2M). This is in agreement with
previous observations of higher levels of TGFβ/activin signalling
and higher expression of pluripotency markers on the edges of
the human pluripotent stem cell colonies (Hough et al., 2009).
The ability to efficiently select for cells of a consistently
highly pluripotent phenotype in cultures, including those
on a large scale, is crucial for providing homogeneously
pluripotent starting material for directed differentiation
protocols, for instance in the generation of cardiomyocytes
and certain neuronal cell types.
We demonstrate that removal of the puromycin selection
causes the emergence of a population of differentiated,
OCT4-negative cells (Fig. 2H). It appears that these spontane-
ously differentiated cells have a cell non-autonomous effect
on the directed neuroepithelial conversion of the whole
population, resulting in a 33% drop in the numbers of
neuroectodermally converted cells as measured by the expres-
sion of PAX6 protein (Fig. 2H and Supplementary Fig. 2D).
The difference in correlation between EGFP and TRA-160
as compared to that between EGFP and SSEA4 or TG30 is
consistent with the observations that extinction dynamics of
TRA-1-60 with differentiation are substantially faster than
that of TG30 or SSEA4 (Fig. 3D and Supplementary Fig. 2).
The dynamic response range and sensitivity of the
EOS(C3+)-EGFP-IRES-Puro reporter is in fact superior to
TRA-1-60, as can be judged from the more rapid and
pronounced downregulation of EGFP than TRA-1-60 follow-
ing RA-induced differentiation (Fig. 3D and Supplementary
Fig. 2C). Similarly, when titrating concentration combina-
tions of FGF2 and TGFβ1, the expression of reporter EGFPcorresponded much more dynamically to variations in these
pluripotency-maintaining factors than TRA-1-60 (Fig. 3E).
In conclusion we have generated and characterised
multiple hES and iPS cell lines that should prove a useful
tool for exploration of the maintenance of pluripotency,
pluripotency extinction and re-emergence in real time,
enabling simple and scalable selection of hPSC populations
that are near homogeneously pluripotent, and undergo more
homogeneous and efficient directed differentiation.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2014.05.006.Acknowledgments
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